4//SEC Filing
Sherman Matthew L 4
Accession 0001209191-23-038756
CIK 0001654151other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 4:05 PM ET
Size
5.0 KB
Accession
0001209191-23-038756
Insider Transaction Report
Form 4
Sherman Matthew L
EVP & Chief Medical Officer
Transactions
- Sale
Common Stock
2023-06-16$14.40/sh−1,655$23,835→ 87,686 total
Footnotes (2)
- [F1]This sale was to cover tax liabilities in the vesting of restricted stock units.
- [F2]Includes 1,196 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 14, 2023.
Documents
Issuer
Deciphera Pharmaceuticals, Inc.
CIK 0001654151
Entity typeother
Related Parties
1- filerCIK 0001325710
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 4:05 PM ET
- Size
- 5.0 KB